Igm Biosciences Inc Share Price

NASDAQ: IGMS

$1.28

-0.02

(-1.15%)

as on August 14, 2025 at 1:29 am IST

$₹

The stock has been delisted from the stock exchange on 12 Aug 2025

Igm Biosciences Inc Stock Performance

as on August 14, 2025 at 1:29 am IST

Day's Low
Day's High
$1.27
Day's Price Range
$1.3
$1.28
0.78%
Downside
1.56%
Upside
52 Week's Low
52 Week's High
$0.92
52-Week Price Range
$20.35
$1.28
28.13%
Downside
1489.84%
Upside

Igm Biosciences Inc share price movements today

Previous Close: $1.30
Open: $1.30
Volume: 776.0K
Day's Low - High: $1.27 - $1.3
52 Week Low - High: $0.92 - $20.35

Igm Biosciences Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Igm Biosciences Inc Stock Fundamentals & Key Indicators

Check Igm Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

0.00%

Igm Biosciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Igm Biosciences Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Igm Biosciences Inc	BUY	$-	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	241.54%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$99.3B	45.88%	27.56	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$60.9B	5.45%	14.49	31.37%

Analyst Recommendation on Igm Biosciences Inc Stock

Based on 15 analysts

BUY

66.67%

Buy

33.33%

Hold

0.00%

Sell

Based on 15 analysts, 66.67% of analysts recommend a 'BUY' rating for Igm Biosciences Inc. Average target price of $1.12

Igm Biosciences Inc Share Price Target

Get share price movements and forecasts by analysts on Igm Biosciences Inc.

What analysts predicted

-14.29%DOWNSIDE

Target Price

$1.12

Current Price

$1.28

Analyzed by

15 Analysts

Target

$1.12

Igm Biosciences Inc target price $1.12, a slight downside of -14.29% compared to current price of $1.28. According to 15 analysts rating.

Igm Biosciences Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	0	0	0	0	0	1	0	0	0	143
Gross Profit	0	-3	-1	-1	-1	-1	0	0	0	143
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-59	-64	-61	-60	-49	-47	-61	-36	-52	97
Net Profit Margin	-11361.88%	-14380.13%	-12178.59%	-9323.35%	-10023.34%	-3819.94%	-11905.04%	-8894.90%	-10599.60%	67.94%

Igm Biosciences Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	0	1	2	2
Gross Profit	0	0	-22	-3	-7	1	-6	-6
Operating Income	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-
Net Income	-11	-22	-42	-80	-160	-214	-246	-195
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-43901.64%	-20041.91%	-11568.83%	-7308.51%

Global Institutional Holdings in Igm Biosciences Inc

Funds	Holdings
Baker Bros Advisors LP	6.79%
Siren, L.L.C.	5.4%
Redmile Group, LLC	4.9%
Sanofi	2.39%
BlackRock Inc	1.71%

See all

Insights on Igm Biosciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 412.0K → 143.62M (in $), with an average increase of 58.5% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -52.89M → 97.58M (in $), with an average increase of 154.2% per quarter
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 64.5% return, outperforming this stock by 149.8%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 84.9% return, outperforming this stock by 180.1%
NEGATIVE IMPACT
Price Dip
In the last 1 year, IGMS stock has moved down by -85.3%

About Igm Biosciences Inc

IGM Biosciences, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing and delivering a new class of medicines to treat patients with cancer and autoimmune and inflammatory diseases. The Company’s pipeline of clinical and preclinical assets is based on the IgM antibody, which has 10 binding sites compared to conventional IgG antibodies with only two binding sites. It is also focused on creating, developing, manufacturing, and commercializing IgM antibody agonists against oncology and immunology and inflammation targets. The Company’s development programs include Aplitabart, Imvotamab, and IGM-2644. Aplitabart is an IgM antibody targeting Death Receptor 5 (DR5) proteins, being evaluated in multiple phase I combination trials for the treatment of colorectal cancer. Imvotamab is a bispecific T cell engaging IgM antibody targeting CD20 and CD3 proteins. IGM-2644 is a bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins.

Organisation	Igm Biosciences Inc
E-voting on shares	Click here to vote

FAQs

What is Igm Biosciences Inc share price today?

Igm Biosciences Inc share price today is $1.28 as on August 14, 2025 at 1:29 am IST at the close of the market. Igm Biosciences Inc share today touched a day high of $1.3 and a low of $1.27.

What is the 52 week high and 52 week low for Igm Biosciences Inc share?

Igm Biosciences Inc share touched a 52 week high of $20.35 on October 22, 2024 and a 52 week low of $0.92 on April 9, 2025. Igm Biosciences Inc stock price today i.e. August 14, 2025 at 1:29 am IST is closed at $1.28,which is 93.71% down from its 52 week high and 39.13% up from its 52 week low.

How to invest in Igm Biosciences Inc Stock (IGMS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Igm Biosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Igm Biosciences Inc Shares that will get you 1.1719 shares as per Igm Biosciences Inc share price of $1.28 per share as on August 14, 2025 at 1:29 am IST.

What is the minimum amount required to buy Igm Biosciences Inc Stock (IGMS) from India?

Indian investors can start investing in Igm Biosciences Inc (IGMS) shares with as little as ₹88.114 or $1 (as of September 18, 2025 at 6:06 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Igm Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 6:06 pm IST). Based on Igm Biosciences Inc share’s latest price of $1.28 as on August 14, 2025 at 1:29 am IST, you will get 7.8125 shares of Igm Biosciences Inc. Learn more about fractional shares .